<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Australia </plain></SENT>
<SENT sid="1" pm="."><plain>The median overall survival for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> is nearly 2 years </plain></SENT>
<SENT sid="2" pm="."><plain>However, there may be survival differences based on site of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Data was collected from the South Australian Registry for Advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 1207 patients with single site <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> at initial diagnosis were subclassified into 6 subgroups: liver only (n = 780), pelvic only (n = 148), lung only (n = 142), lymph node only (n = 95), bone only (n = 32), and brain only (n = 10) </plain></SENT>
<SENT sid="5" pm="."><plain>Univariate and multivariate parametric survival analyses were performed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Median overall survival was 20.3 months for the whole group </plain></SENT>
<SENT sid="7" pm="."><plain>The overall survival for lung-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> group was 41.1 months followed by liver- and pelvic-only disease groups (22.8 and 23.8 months, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with isolated bone-only and brain-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> had poor overall survival (5.1 and 5.7 months, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>On multivariate analysis, prognosis was superior for the lung-only group </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Lung only group had the longest median overall survival </plain></SENT>
<SENT sid="11" pm="."><plain>Bone and brain sites had a poor outlook </plain></SENT>
<SENT sid="12" pm="."><plain>Site of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> at initial presentation may be prognostic </plain></SENT>
</text></document>